Silent Persistence: Molecular Evidence of Clonal Transmission in Fluconazole-Resistant Candida parapsilosis Hospital

Cihan Semet1, Esra Kazak1, Seçil Ak-Aksoy2

  • 1Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bursa Uludağ University, Bursa 16059, Turkey.

PubMed

Insights

Fluconazole-resistant Candida parapsilosis bloodstream infections show limited genetic diversity, with two dominant clones persisting for years in hospitals. Enhanced infection control is crucial to prevent sustained clonal transmission of this nosocomial pathogen.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Molecular Epidemiology

Background:

  • Fluconazole-resistant Candida parapsilosis is a growing cause of hospital-acquired infections.
  • Understanding the genetic basis of its persistence in healthcare settings is critical.

Purpose of the Study:

  • To characterize the long-term molecular epidemiology of fluconazole-resistant Candida parapsilosis bloodstream isolates.
  • To investigate genetic diversity and clonal transmission patterns over 22 years.

Main Methods:

  • Analysis of 47 bloodstream isolates collected between 1997 and 2019.
  • Microsatellite analysis using three polymorphic markers (CP1, CP4, B5).
  • Phylogenetic analysis to assess genetic diversity and clonal relationships.

Main Results:

  • Minimal genetic diversity was observed, with only six distinct genotypes identified.
  • Two dominant clones accounted for over 70% of isolates and persisted throughout the study period.
  • Evidence of spatiotemporal clustering in surgical and intensive care units.

Conclusions:

  • Findings suggest prolonged, multi-year clonal transmission of fluconazole-resistant Candida parapsilosis.
  • Higher-resolution genomics and epidemiologic linkage are needed for definitive confirmation.
  • Strengthened infection control measures are essential to combat sustained hospital-based transmission.